Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS4 Cap. Regulatory News (SFOR)

Share Price Information for S4 Cap. (SFOR)

Share Price is delayed by 15 minutes
Get Live Data
41.55    -1.75 (-4.04%)
Bid:
41.30
Ask:
42.00
Spread: 0.70 (1.695%)
Market Cap: £276.67m
SFOR Live PriceLast checked at - London Stock Exchange

Intraday S4 Cap. Share Chart

Trading Update

24 Nov 2025 07:00

RNS Number : 6303I
S4 Capital PLC
24 November 2025
 

24 November 2025 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO. 596/2014 ON MARKET ABUSE ("UK MAR"), AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018

 

 

 

S4 Capital plc

("S4 Capital" or the "Company")

 

Trading Update

 

Following the release of our third quarter trading update in early November, we have received and reviewed both the Company's financial results for October and the third quarter revised forecast for 2025, which show a decrease in net revenue versus the forecast and therefore impacts our fourth quarter performance.

 

2025 like-for-like net revenue is now expected to be down by just under 10%. Despite the cost actions we have already taken this year, this decline in net revenue will impact our operational EBITDA, which we are now targeting to be approximately £75 million, below the current market consensus of £81.6 million. This is mainly as a result of lower project-based revenue, continued client caution and a slower ramp up of our new business wins than expected.

 

Despite this, our liquidity continues to improve more than anticipated and our targeted range for the year end net debt remains £100 million to £140 million.

 

 

Enquiries:

 

S4 Capital Tel: +44 (0)20 3793 0003

Sir Martin Sorrell (Executive Chairman)

 

About S4 Capital

 

Our strategy is to build a purely digital advertising and marketing services business for global, multinational, regional, and local clients, and millennial-driven influencer brands. This will be achieved by integrating leading businesses in two synchronised Practices: Marketing Services and Technology services, along with an emphasis on 'faster, better, cheaper, more' execution in an always-on consumer-led environment, with a unitary structure. The Company now has approximately 6,500 people in 33 countries with approximately 80% of net revenue across the Americas, 15% across Europe, the Middle East and Africa and 5% across Asia-Pacific. The longer-term objective is a geographic split of 60%:20%:20%. Marketing Services accounted for approximately 90% of net revenue, and Technology Services 10%. The longer term objective is a practice split of 75%:25%. Sir Martin was CEO of WPP for 33 years, building it from a £1 million 'shell' company in 1985 into the world's largest advertising and marketing services company, with a market capitalisation of over £16 billion on the day he left. Prior to that Sir Martin was Group Financial Director of Saatchi & Saatchi Company Plc for nine years.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPGGWGUPAGRW
Date   Source Headline
4th Jun 20264:30 pmRNSResults of 2026 Annual General Meeting
4th Jun 20267:00 amRNSAGM Statement
13th May 20266:00 pmRNSNotice of AGM
7th May 20267:00 amRNSFirst Quarter Trading Update
30th Apr 20265:00 pmRNSHolding(s) in Company
24th Apr 20265:45 pmRNSAnnual Report and Accounts
15th Apr 20267:00 amRNSNotice of Q1 Trading Update
26th Mar 202612:58 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSAudited 2025 Results
26th Feb 20267:00 amRNSNotice of Results
26th Jan 20267:00 amRNSFourth Quarter Trading Update
1st Dec 20257:00 amRNSTotal Voting Rights
24th Nov 20257:00 amRNSTrading Update
14th Nov 202512:15 pmRNSBoard Changes
6th Nov 20257:01 amRNSTotal Voting Rights
6th Nov 20257:00 amRNSThird Quarter Trading Update
5th Nov 20257:00 amRNSIssue of Shares
17th Oct 20259:00 amRNSNotice of Q3 Trading Update
3rd Oct 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSIssue of Shares
15th Sep 20257:00 amRNSInterim Results for 2025
1st Sep 202511:04 amRNSTotal Voting Rights and Capital
22nd Aug 20257:00 amRNSNotice of Results
15th Aug 20257:00 amRNSIssue of Shares
11th Aug 20257:00 amRNSResponse to Press Speculation
1st Aug 20259:15 amRNSTotal Voting Rights
25th Jul 20257:00 amRNSIssue of Shares
17th Jul 20253:02 pmRNSHolding(s) in Company
3rd Jul 20254:30 pmRNSBoard Change
4th Jun 20253:03 pmRNSResult of AGM
4th Jun 20257:00 amRNSS4 Capital AGM statement
16th May 20253:01 pmRNSDirector/PDMR Shareholding
9th May 20252:30 pmRNSNotice of AGM
8th May 20257:00 amRNSS4 Capital Q1 2025 Trading Update
1st May 20257:00 amRNSBoard Appointments
25th Apr 202511:39 amRNSNotice of Q1 Trading Update
3rd Apr 20259:11 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSAudited 2024 Results
17th Mar 20257:00 amRNSNotice of Results
28th Jan 20257:00 amRNSFourth Quarter Trading Update
9th Jan 20257:00 amRNSManagement Change
2nd Dec 20243:55 pmRNSTotal Voting Rights
15th Nov 20243:30 pmRNSDirector/PDMR Shareholding
15th Nov 20247:00 amRNSIssue of Shares
7th Nov 20247:00 amRNSThird Quarter Trading Update
4th Nov 20247:00 amRNSNotice of Q3 Trading Update
1st Nov 20249:00 amRNSTotal Voting Rights
9th Oct 20247:00 amRNSIssue of Shares
7th Oct 20247:00 amRNSIssue of Shares
19th Sep 20247:00 amRNSInterim Results for 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.